Lipid profile in ambulatory subjects using 3 point-of-care devices and comparison with reference methods

Point of Care

Volumn 9, Issue 2, 2010, Pages 102-107

  Mendez Gonzalez J ^a   Bonet Marques R ^a   Ordóñez Llanos, Jordi ^a,b  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Accutrend GCT; Accutrend plus; CardioChek; Dyslipemia; Point of care

Indexed keywords

EID: 77953106059     PISSN: 1533029X     EISSN: 15330303     Source Type: Journal    
DOI: 10.1097/POC.0b013e3181d9f3cc     Document Type: Article

References (19)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143-3421.
2. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
3. McNamara JR, Cohn JS, Wilson PW, et al. Calculated values for low-density lipoprotein cholesterol in the assessment of lipid abnormalities and coronary disease risk. Clin Chem. 1990;36:36-42.
4. Nauck M, Warnick GR, Rifai N. Methods for measurement of LDL-cholesterol: a critical assessment of direct measurement by homogeneous assays versus calculation. Clin Chem. 2002;48:236-254.
5. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: third joint task force of European and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of eight societies and by invited experts). Atherosclerosis. 2004;173:381-391.
6. Tsuyuki RT, Johnson JA, Teo KK, et al. Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP): a randomized trial design of the effect of a community pharmacist intervention program on serum cholesterol risk. Ann Pharmacother. 1999;33:910-919.
7. Hainline AKJ, Lippel K, eds. Lipid Research Clinic Program. Manual of Laboratory Operations, Lipid and Lipoprotein Analysis. Bethesda, MD: National Heart, Lung and Blood Institute; 1982.
8. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
9. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med. 2002;162:1149-1155.
10. Current status of blood cholesterol measurement in clinical laboratories in the United States: a report from the Laboratory Standardization Panel of the National Cholesterol Education Program. Clin Chem. 1988;34:193-201.
11. Gottschling HD, Reuter W, Ronquist G, et al. Multicentre evaluation of a non-wipe system for the rapid determination of total cholesterol in capillary blood, Accutrend Cholesterol on Accutrend GC. Eur J Clin Chem Clin Biochem. 1995;33:373-381.
12. Shephard MD, Mazzachi BC, Shephard AK. Comparative performance of two point-of-care analysers for lipid testing. Clin Lab. 2007;53:561-566.
13. Dale RA, Jensen LH, Krantz MJ. Comparison of two point-of-care lipid analyzers for use in global cardiovascular risk assessments. Ann Pharmacother. 2008;42:633-639.
14. Panz VR, Raal FJ, Paiker J, et al. Performance of the CardioChek PA and Cholestech LDX point-of-care analysers compared to clinical diagnostic laboratory methods for the measurement of lipids. Cardiovasc J S Afr. 2005;16:112-117.
15. Superko HR, Krauss RM. Differential effects of nicotinic acid in subjects with different LDL subclass patterns. Atherosclerosis. 1992;95:69-76.
16. Patsch JR, Miesenbock G, Hopferwieser T, et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb. 1992;12:1336-1345.
17. Luley C, Ronquist G, Reuter W, et al. Point-of-care testing of triglycerides: evaluation of the Accutrend triglycerides system. Clin Chem. 2000;46:287-291.
18. Moses RG, Calvert D, Storlien LH. Evaluation of the Accutrend GCT with respect to triglyceride monitoring. Diabetes Care. 1996;19:1305-1306.
19. Taylor JR, Lopez LM. Cholesterol: point-of-care testing. Ann Pharmacother. 2004;38:1252-1257.